Drug intelligence / Profile preview

bis(adenosine)-5'-triphosphate

Development stage: Unknown
Modality: Small Molecules

Overview

Bis(adenosine)-5'-triphosphate is a synthetic dinucleotide composed of two adenosine molecules linked via a triphosphate bridge at the 5' position of each ribose. It belongs to the class of (5'→5') dinucleotides, which are characterized by their unique phosphodiester linkage. This compound is classified as an experimental small molecule and has not been approved for clinical use in any country. Its mechanism of action and pharmacological effects are not well established, and it does not have any known therapeutic indications or ongoing clinical trials[1][2][8].

Other names: Bis(Adenosine)-5'-Triphosphate

Targets

FHIT (Fragile histidine triad diadenosine triphosphatase)

Beyond the preview

Go deeper on bis(adenosine)-5'-triphosphate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bis(adenosine)-5'-triphosphate.

Explore the full profile